Cumberland Pharmaceuticals Inc.: accounts_payable
| Value | {"amount": 19554251, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:08.051287+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/504f0586-a6b9-4946-805d-0790278ce398
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001087294-26-000062Retrieved: 2026-08-19T10:49:08.051287+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/accounts-payable/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/504f0586-a6b9-4946-805d-0790278ce398
History
- no predecessors — first report